P. Bongioanni et al., LYMPHOCYTE SUBSETS IN MULTIPLE-SCLEROSIS - A STUDY WITH 2-COLOR FLUORESCENCE ANALYSIS, Journal of the neurological sciences, 139(1), 1996, pp. 71-77
Multiple sclerosis (MS) is postulated to be an immunopathologically me
diated disease. This concept is supported by the finding of abnormally
distributed peripheral blood T-cell subsets and a decreased T-suppres
sor function. Thirty-seven MS patients have been selected according to
the criteria for definite MS. Fluorescein- or phycoerythrin-conjugate
d monoclonal antibodies have been used to define different lymphocyte
subsets: CD4(+), CD5(+), CD8(+), CD19(+), CD38(+), CD45RA(+), CD4(+)CD
45RA(+), CD19(+)CD5(+), CD8(+)CD38(+) In relapsing-remitting (RR)-MS p
atients a significantly decreased percentage of CD19(+) cells and in p
rogressive MS patients a significantly increased percentage of CD19(+)
CD5(+) cells have been found. During a relapse in RR-MS, a significant
ly decreased percentage of CD4(+)CD45RA(+) cells and a significantly i
ncreased percentage of CD8(+)CD38(+) cells have been observed. Moreove
r, in RR-MS patients a significantly increased percentage of CD38(+) c
ells and significantly high IgM amounts have been found. The increased
percentage of CD19(+)CD5(+) and CD38(+) cells (together with high IgM
levels) and the reduced percentage of CD4(+)CD45RA(+) lymphocytes cou
ld be related to an activation of both cellular and humoral immune res
ponse in acute MS.